CAS RN 179324-69-7
Bortezomib, TRC
CAS: 179324-69-7 Molekylformel: C19 H25 B N4 O4 Molekylvikt (g/mol): 384.24 Synonym: Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-,Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]- (9CI),Boronic acid, [3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, [S-(R*,S*)]-,Bortezomib,DPBA,LDP 341,MG 341,MLN 341,NSC 681239,PS 314,PS 341,PS 341 (pharmaceutical),Radiciol,Velcade IUPAC-namn: [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid LEDER: CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O
Tocris Bioscience™ Bortezomib
High affinity proteasome inhibitor
Bortezomib, MedChemExpress
MedChemExpress Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity.
Bortezomib, 98%
CAS: 179324-69-7 Molekylformel: C19H25BN4O4 Molekylvikt (g/mol): 384.243 MDL-nummer: MFCD09056737 InChI-nyckel: GXJABQQUPOEUTA-RDJZCZTQSA-N Synonym: bortezomib,velcade,bortezomib ps-341,dpba,pyz-phe-boroleu,unii-69g8bd63pp,velcade tn,bortezomib velcade,1r-3-methyl-1-2s-1-oxo-3-phenyl-2-pyrazinylcarbonyl amino propyl amino butyl boronic acid,1r-3-methyl-1-2s-3-phenyl-2-pyrazine-2-carbonylamino propanoyl amino butyl boronic acid PubChem CID: 387447 ChEBI: CHEBI:52717 IUPAC-namn: [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid LEDER: B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O